Valuation
- Market cap
- 923,000
- Revenue TTM
- $16,000,000
- Net income TTM
- $-2,400,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -15.00%
- Debt to equity
- -0.75
Trading
- Volume
- 13,400
- Avg volume
- 36,448
- Day's range
- $0.05 – $0.05
- Shares out
- 20,075,000
- Stochastic %K
- 17%
- Beta
- 1.21
- Analysts
- Strong Buy
- Price target
- $4.00
Company profile
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes f...
Show more
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It also offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 800 590 4155
- Website
- https://www.biotricity.com
- Address
- 203 Redwood Shores Parkway, Suite 600, Redwood City, United States
Latest news
No headlines yet.